| TENAX THERAPEUTICS |
| USA |
| Gesundheit |
| US88032L6056 / A3EVQN |
| YBO0 (Frankfurt) / TENX (NASDAQ) |
| FRA:YBO0, ETR:YBO0, YBO0:GR, NASDAQ:TENX |
| - |
| https://tenaxthera.com/ |
|
Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapies for cardiovascular and pulmonary diseases with significant unmet medical need. The company’s current pipeline centers on cardiopulmon..
>Volltext.. |
| 435.16 Mio. EUR |
| 333.09 Mio. EUR |
| - |
| -59.36 Mio. EUR |
| -56.12 Mio. EUR |
| -1.28 EUR |
| - |
| 102.07 Mio. EUR |
| -39.82 Mio. EUR |
| 14.61 |
| - |
| -106.03% |
| - |
| - |
| - |
| - |
| TENAX THERAPEUTICS, TENAX THERAPEUTIC |
| 10.08.26 |